Cell Guidance Systems provides cytogenetics services including G-banding karyotype analysis, array Comparative Genome Hybridization (aCGH) and Array Genome Hybridization (AGH) to assess cell quality and the presence of abnormalities.
Induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs) are prone to acquiring genetic abnormalities in vitro. These cytogenetic changes may influence cell quality, potentially leading to inaccurate results in downstream experiments. Furthermore, genomic instability may be a concern if considering the future use of iPSCs and ESCs in cell therapies.
All of Cell Guidance Systems' cytogenetics services are carried out by experienced, clinically qualified cytogeneticists.